About Labcorp Holdings Inc.
https://www.labcorp.comLabcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
CEO
Adam H. Schechter
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2023-07-03 | Forward | 291:250 |
| 2002-05-13 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 644
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
UBS
Buy
Truist Securities
Buy
Citigroup
Buy
Jefferies
Buy
Mizuho
Outperform
Evercore ISI Group
Outperform
Grade Summary
Showing Top 6 of 11
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:9.81M
Value:$2.57B
BLACKROCK INC.
Shares:9.49M
Value:$2.49B
BLACKROCK, INC.
Shares:8.13M
Value:$2.13B
Summary
Showing Top 3 of 1,370
About Labcorp Holdings Inc.
https://www.labcorp.comLabcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $3.56B ▲ | $628.5M ▼ | $261.1M ▲ | 7.33% ▲ | $3.14 ▲ | $564M ▲ |
| Q2-2025 | $3.53B ▲ | $651.7M ▲ | $237.9M ▲ | 6.74% ▲ | $2.86 ▲ | $532.1M ▲ |
| Q1-2025 | $3.35B ▲ | $622M ▼ | $212.8M ▲ | 6.36% ▲ | $2.54 ▲ | $498M ▲ |
| Q4-2024 | $3.33B ▲ | $679.8M ▲ | $143.4M ▼ | 4.31% ▼ | $1.72 ▼ | $417.8M ▼ |
| Q3-2024 | $3.28B | $650.3M | $169.3M | 5.16% | $2.02 | $422.5M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $598.1M ▼ | $18.26B ▲ | $9.55B ▼ | $8.7B ▲ |
| Q2-2025 | $647.3M ▲ | $18.06B ▲ | $9.57B ▲ | $8.47B ▲ |
| Q1-2025 | $369.4M ▼ | $17.6B ▼ | $9.28B ▼ | $8.31B ▲ |
| Q4-2024 | $1.52B ▲ | $18.38B ▼ | $10.31B ▼ | $8.05B ▼ |
| Q3-2024 | $1.52B | $18.61B | $10.43B | $8.17B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 ▼ | $387.2M ▼ | $-374M ▼ | $-59.5M ▲ | $-49.2M ▼ | $280.5M ▼ |
| Q2-2025 | $238.3M ▲ | $620.6M ▲ | $-94.1M ▲ | $-267.4M ▲ | $277.9M ▲ | $542.7M ▲ |
| Q1-2025 | $213M ▲ | $18.5M ▼ | $-336M ▼ | $-839.7M ▼ | $-1.15B ▼ | $-107.5M ▼ |
| Q4-2024 | $143.6M ▼ | $777.2M ▲ | $-209.6M ▲ | $-546.7M ▼ | $1.4M ▼ | $665.1M ▲ |
| Q3-2024 | $169.6M | $277.3M | $-579.1M | $1.55B | $1.25B | $161.5M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 LabCorp Diagnostics | $2.59Bn ▲ | $2.63Bn ▲ | $2.75Bn ▲ | $2.77Bn ▲ |
Revenue by Geography
| Region | Q3-2021 | Q4-2021 | Q3-2025 | Q2-2025 |
|---|---|---|---|---|
 UNITED STATES | $3.35Bn ▲ | $0 ▼ | $2.97Bn ▲ | $2.93Bn ▼ |
 Europe | $0 ▲ | $2.05Bn ▲ | $0 ▼ | $0 ▲ |
 North America | $0 ▲ | $13.09Bn ▲ | $0 ▼ | $0 ▲ |
 Other Countries | $0 ▲ | $980.00M ▲ | $0 ▼ | $0 ▲ |
CEO
Adam H. Schechter
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2023-07-03 | Forward | 291:250 |
| 2002-05-13 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 644
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
UBS
Buy
Truist Securities
Buy
Citigroup
Buy
Jefferies
Buy
Mizuho
Outperform
Evercore ISI Group
Outperform
Grade Summary
Showing Top 6 of 11
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:9.81M
Value:$2.57B
BLACKROCK INC.
Shares:9.49M
Value:$2.49B
BLACKROCK, INC.
Shares:8.13M
Value:$2.13B
Summary
Showing Top 3 of 1,370